Engineered Heart Tissues for Contractile, Structural, and Transcriptional Assessment of Human Pluripotent Stem Cell-Derived Cardiomyocytes in a Three-Dimensional, Auxotonic Environment

Methods Mol Biol. 2022:2485:87-97. doi: 10.1007/978-1-0716-2261-2_6.

Abstract

Three-dimensional, human engineered heart tissue promotes maturation of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and provides a useful platform for in vitro cardiac development and disease modeling. This protocol describes the generation of fibrin-based engineered heart tissues (EHTs) containing hiPSC-CMs and human stromal cells. The platform makes use of racks of silicone posts that fit a standard 24-well dish. Stromal cells and hiPSC-CMs are cast in a fibrin hydrogel suspended between two silicone posts, forming an engineered tissue that generates synchronous contractions. The platform described herein is amenable to various measures of cardiac function including measurement of contractile force and calcium handling, as well as molecular biology assays and immunostaining.

Keywords: Cardiac tissue engineering; Cardiomyocytes; Engineered heart tissue; Fibrin; Induced pluripotent stem cells.

MeSH terms

  • Fibrin
  • Humans
  • Induced Pluripotent Stem Cells* / cytology
  • Myocytes, Cardiac* / cytology
  • Silicones
  • Tissue Engineering*

Substances

  • Silicones
  • Fibrin